Goal 3 - Good health and well-being

  1. Home /
  2. Goal 3
  3. / Indicator 3.b.1

Indicator 3.b.1 - Proportion of the target population covered by all vaccines included in their national programme

.

Unit: percent [%]
Source of data: WHO

Information about indicator

Name of the indicator 3.b.1 Proportion of the target population covered by all vaccines included in their national programme
Sustainable Development Goal Goal 3. Good health and well-being
Target 3.b Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all
Definition Proportion of the target population covered by all vaccines included in their national programme.
Unit percent [%]
Available dimensions type of vaccinaton
Methodological explanations

This indicator aims to measure access to vaccines, including the newly available or underutilized vaccines, at the national level.

The vaccines taken into consideration are as follows:

· DTP3 - third dose of Diphtheria-tetanus-pertussis containing vaccine; data present the percentage of surviving infants who received the 3 doses of diphtheria and tetanus toxoid with pertussis containing vaccine in a given year according to nationally recommended schedule;

· MCV2 - second dose of Measles containing vaccine; data present the percentage of children who received two dose of measles containing vaccine according to nationally recommended schedule through routine immunization services in a given year,

· PCV3 - third, final dose of Pneumococcal conjugate vaccine; data present the percentage of surviving infants who received the nationally recommended doses of pneumococcal conjugate vaccine in a given year,

· HPV - Human papillomavirus infection vaccine (last dose in the schedule); data present the percentage of 15 years old girls received the recommended doses of HPV vaccine.
Source of data WHO
Data availability Annual data, since 2010 (for PCV3 – since 2018)
Notes Estimated data, calculated by WHO. No estimate for Poland for the HPV vaccine.
Data updated on 24-10-2023
Metadata updated on 24-02-2021